SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-22-235284
Filing Date
2022-08-31
Accepted
2022-08-31 17:07:39
Documents
10
Period of Report
2022-08-31

Document Format Files

Seq Description Document Type Size
1 PREM14A d359803dprem14a.htm PREM14A 1433894
2 EX-FILING FEES d359803dexfilingfees.htm EX-FILING FEES 20726
3 GRAPHIC g359803g00v66.jpg GRAPHIC 27297
4 GRAPHIC g359803g04p02.jpg GRAPHIC 63777
5 GRAPHIC g359803g08a23.jpg GRAPHIC 24953
6 GRAPHIC g359803g19p37.jpg GRAPHIC 57349
7 GRAPHIC g359803g37p88.jpg GRAPHIC 52759
8 GRAPHIC g359803g88p19.jpg GRAPHIC 52381
9 GRAPHIC g359803v11g11.jpg GRAPHIC 140622
10 GRAPHIC g359803v1g2.jpg GRAPHIC 146467
  Complete submission text file 0001193125-22-235284.txt   2228559
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-35420 | Film No.: 221218648
SIC: 2834 Pharmaceutical Preparations